Biofil Chemicals and Pharmaceuticals Limited
NSE: BIOFILCHEM BSE: BIOFILCHEM
Prev Close
50.85
Open Price
51.56
Volume
48,996
Today Low / High
48.05 / 51.56
52 WK Low / High
40.4 / 91.87
Range
47 - 52
Prev Close
50.96
Open Price
50.8
Volume
6,274
Today Low / High
46.21 / 50.96
52 WK Low / High
40.5 / 92
Range
47 - 52
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 49.24 (target range: 47 - 52), reflecting a change of -1.61 (-3.16618%). On the BSE, it is listed at 49.53 (target range: 47 - 52), showing a change of -1.43 (-2.80612%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.
Biofil Chemicals and Pharmaceuticals Limited Graph
Biofil Chemicals and Pharmaceuticals Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Biofil Chemicals and Pharmaceuticals Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 49.24, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 49.53 | 50.03 | 45.02 - 55.03 |
| 50.52 | 40.42 - 60.62 | ||
| 51.02 | 35.71 - 66.32 | ||
| Bearish Scenario | 49.53 | 49.03 | 44.13 - 53.94 |
| 48.54 | 38.83 - 58.25 | ||
| 48.04 | 33.63 - 62.46 |
Overview of Biofil Chemicals and Pharmaceuticals Limited
ISIN
INE829A01014
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
34,078
Market Cap
715,396,248
Last Dividend
0
Official Website
IPO Date
2017-07-27
DCF Diff
34.30
DCF
9
Financial Ratios Every Investor Needs
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 40.04 Cr | 37.51 Cr | 2.53 Cr | 0.0631 | 0.00 Cr | 0.14 Cr | 0.42 Cr | 0.71 Cr | 0.44 | 1.31 Cr | 0.0177 |
| 2023-03-31 | 30.04 Cr | 27.47 Cr | 2.56 Cr | 0.0853 | 0.00 Cr | 0.14 Cr | 0.74 Cr | 0.56 Cr | 0.34 | 1.26 Cr | 0.0187 |
| 2022-03-31 | 22.38 Cr | 19.52 Cr | 2.87 Cr | 0.1280 | 0.00 Cr | 0.19 Cr | 0.91 Cr | 0.70 Cr | 0.43 | 1.48 Cr | 0.0312 |
| 2021-03-31 | 35.75 Cr | 32.48 Cr | 3.27 Cr | 0.0914 | 0.01 Cr | 0.18 Cr | 1.19 Cr | 1.24 Cr | 0.76 | 2.40 Cr | 0.0347 |
| 2020-03-31 | 29.69 Cr | 27.46 Cr | 2.23 Cr | 0.0750 | 0.00 Cr | 0.13 Cr | 1.42 Cr | 1.21 Cr | 0.74 | 1.99 Cr | 0.0407 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 2.28 Cr | 47.08 Cr | 28.88 Cr | 18.2028 Cr | 0.44 Cr | -1.84 Cr | 2.55 Cr | 8.62 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 28.5245 Cr |
| 2023-03-31 | 0.03 Cr | 31.41 Cr | 14.10 Cr | 17.3015 Cr | 0.52 Cr | 0.48 Cr | 1.21 Cr | 9.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 13.7255 Cr |
| 2022-03-31 | 0.15 Cr | 18.73 Cr | 1.89 Cr | 16.8377 Cr | 0.46 Cr | 0.32 Cr | 1.29 Cr | 9.42 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 1.4947 Cr |
| 2021-03-31 | 0.44 Cr | 33.24 Cr | 17.11 Cr | 16.1291 Cr | 0.43 Cr | -0.01 Cr | 4.34 Cr | 9.78 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 16.7531 Cr |
| 2020-03-31 | 0.26 Cr | 42.36 Cr | 27.48 Cr | 14.8832 Cr | 1.19 Cr | 0.94 Cr | 1.69 Cr | 10.09 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 27.4816 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 2.3937 Cr | -0.0229 Cr | -0.1249 Cr | 2.3708 Cr | 2.2459 Cr | 2.2835 Cr | -0.0229 Cr | 0.7092 Cr | -0.0834 Cr | 0.0000 Cr | -1.3363 Cr |
| 2023-03-31 | -0.1118 Cr | -0.0106 Cr | 0.0151 Cr | -0.1224 Cr | -0.1073 Cr | 0.0376 Cr | -0.0106 Cr | 0.7930 Cr | 0.0576 Cr | 0.0000 Cr | 0.0797 Cr |
| 2022-03-31 | -0.2199 Cr | -0.0699 Cr | -0.0058 Cr | -0.2898 Cr | -0.2956 Cr | 0.1449 Cr | -0.0699 Cr | 0.6984 Cr | 0.0348 Cr | 0.0000 Cr | 3.0514 Cr |
| 2021-03-31 | 1.1109 Cr | -0.0961 Cr | -0.8303 Cr | 0.5442 Cr | 0.1845 Cr | 0.4405 Cr | -0.5667 Cr | 1.9189 Cr | -0.7622 Cr | 0.0000 Cr | -2.6524 Cr |
| 2020-03-31 | 0.8942 Cr | -0.2067 Cr | -0.5676 Cr | 0.6875 Cr | 0.1198 Cr | 0.2560 Cr | -0.2067 Cr | 1.4641 Cr | -0.4453 Cr | 0.0000 Cr | -0.5012 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 14.20 Cr | 13.62 Cr | 0.57 Cr | 0.0403 | 0.21 Cr | 0.16 Cr | 0.10 | 0.33 Cr | 0.0116 |
| 2024-09-30 | 2.41 Cr | 2.05 Cr | 0.36 Cr | 0.1505 | 0.03 Cr | 0.02 Cr | 0.02 | 0.14 Cr | 0.0101 |
| 2024-06-30 | 8.44 Cr | 7.72 Cr | 0.73 Cr | 0.0862 | 0.59 Cr | 0.17 Cr | 0.10 | 0.34 Cr | 0.0201 |
| 2024-03-31 | 15.20 Cr | 15.01 Cr | 0.19 Cr | 0.0127 | -0.11 Cr | 0.25 Cr | 0.15 | 0.37 Cr | 0.0164 |
| 2023-12-31 | 5.03 Cr | 4.57 Cr | 0.46 Cr | 0.0916 | 0.16 Cr | 0.09 Cr | 0.06 | 0.22 Cr | 0.0185 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 0.16 Cr | 0.06 Cr | 0.22 Cr | 25.51 Cr | 6.80 Cr | 33.61 Cr | 8.43 Cr | 42.04 Cr | 23.64 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 2.28 Cr | 0.00 Cr | 0.00 Cr | 2.28 Cr | 0.00 Cr | 0.00 Cr | -18.20 Cr |
| 2024-03-31 | 2.28 Cr | 2.19 Cr | 2.28 Cr | 33.03 Cr | 2.55 Cr | 38.41 Cr | 8.62 Cr | 47.08 Cr | 28.88 Cr |
| 2023-12-31 | -0.06 Cr | 0.12 Cr | 0.06 Cr | 0.00 Cr | 0.00 Cr | 0.06 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-09-30 | 0.03 Cr | 0.02 Cr | 0.06 Cr | 27.40 Cr | 5.07 Cr | 33.43 Cr | 8.79 Cr | 42.22 Cr | 24.55 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-06-30 | 0.17 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 0.25 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | 0.09 Cr | 0.21 Cr | 0.00 Cr | 0.00 Cr | 0.21 Cr | 0.27 Cr | 0.06 Cr | 0.00 Cr | 0.21 Cr |
| 2023-09-30 | 0.12 Cr | 0.21 Cr | 0.00 Cr | 0.00 Cr | 0.21 Cr | 0.06 Cr | 0.00 Cr | 0.00 Cr | 0.21 Cr |
| 2023-06-30 | 0.24 Cr | 0.21 Cr | 0.00 Cr | 0.00 Cr | 0.21 Cr | 0.25 Cr | 0.04 Cr | 0.00 Cr | 0.21 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,677.60 | ₹4,025,032,128,000.00 | ₹3,640,552.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,612.00 | ₹1,755,281,028,000.00 | ₹786,577.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹3,174.70 | ₹1,074,461,341,500.00 | ₹484,230.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,251.20 | ₹1,042,391,010,624.00 | ₹3,161,380.00 |
| Mankind Pharma Limited | MANKIND | ₹2,467.70 | ₹1,018,348,350,085.00 | ₹821,537.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹930.00 | ₹935,793,900,000.00 | ₹1,896,230.00 |
| Lupin Limited | LUPIN | ₹1,957.70 | ₹893,919,100,900.00 | ₹1,340,783.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,147.80 | ₹666,644,535,600.00 | ₹2,022,114.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,098.50 | ₹609,602,152,500.00 | ₹724,797.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹1,457.10 | ₹411,195,077,100.00 | ₹1,334,065.00 |
| Cohance Lifesciences Limited | COHANCE | ₹1,047.70 | ₹400,815,454,282.00 | ₹358,137.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,424.80 | ₹361,477,459,200.00 | ₹330,987.00 |
| Laurus Labs Limited | LAURUSLABS | ₹609.60 | ₹328,728,628,800.00 | ₹791,048.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,510.80 | ₹313,629,049,600.00 | ₹126,900.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,676.30 | ₹261,142,395,500.00 | ₹101,214.00 |
| Piramal Enterprises Limited | PEL | ₹1,108.20 | ₹251,204,559,600.00 | ₹424,622.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,465.30 | ₹238,080,478,700.00 | ₹2,103,984.00 |
| Eris Lifesciences Limited | ERIS | ₹1,581.80 | ₹215,417,433,000.00 | ₹178,142.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹1,018.05 | ₹200,110,962,150.00 | ₹139,071.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹7,972.00 | ₹199,300,000,000.00 | ₹15,250.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹1,173.80 | ₹186,964,037,800.00 | ₹373,379.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹2,152.60 | ₹163,622,785,420.00 | ₹49,324.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹883.40 | ₹158,225,774,000.00 | ₹630,952.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹11,503.00 | ₹147,582,339,700.00 | ₹41,530.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Granules India Limited | GRANULES | ₹530.55 | ₹128,681,719,200.00 | ₹1,110,969.00 |
| Procter & Gamble Health Limited | PGHL | ₹5,748.00 | ₹95,413,351,200.00 | ₹15,452.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹901.40 | ₹88,148,717,260.00 | ₹578,677.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹911.00 | ₹82,568,138,820.00 | ₹398,631.00 |
| Strides Pharma Science Limited | STAR | ₹811.10 | ₹74,753,165,970.00 | ₹1,589,442.00 |
| FDC Limited | FDC | ₹438.90 | ₹71,457,309,000.00 | ₹184,916.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹185.15 | ₹60,085,248,300.00 | ₹2,196,848.00 |
| Suven Life Sciences Limited | SUVEN | ₹244.86 | ₹53,397,599,640.00 | ₹1,075,673.00 |
| Innova Captab Limited | INNOVACAP | ₹878.45 | ₹50,269,239,759.00 | ₹49,937.00 |
| Sequent Scientific Limited | SEQUENT | ₹191.84 | ₹48,017,935,680.00 | ₹632,917.00 |
| Hikal Limited | HIKAL | ₹372.15 | ₹45,886,467,150.00 | ₹283,074.00 |
| Unichem Laboratories Limited | UNICHEMLAB | ₹598.20 | ₹42,116,749,560.00 | ₹19,239.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹443.85 | ₹40,510,189,500.00 | ₹1,275,270.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹391.00 | ₹39,208,698,000.00 | ₹42,595.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹2,181.20 | ₹36,074,866,800.00 | ₹7,567.00 |
| Morepen Laboratories Limited | MOREPENLAB | ₹64.84 | ₹35,529,337,360.00 | ₹3,361,736.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹628.75 | ₹31,889,634,125.00 | ₹1,737,877.00 |
| Alembic Limited | ALEMBICLTD | ₹110.53 | ₹28,382,114,349.00 | ₹424,168.00 |
| IOL Chemicals and Pharmaceuticals Limited | IOLCP | ₹87.92 | ₹25,806,893,840.00 | ₹796,204.00 |
Key Executives
Gender: male
Year Born: 1961
Gender: Not Specified
Year Born: 1961
Gender: Not Specified
Year Born: 1974
Gender: male
Year Born: 1991
FAQs about Biofil Chemicals and Pharmaceuticals Limited
The CEO is Mr. Pavan Singh Rajput.
The current price is ₹43.96.
The range is ₹40.4-91.87.
The market capitalization is ₹71.54 crores.
The P/E ratio is 119.19.
The company operates in the Healthcare sector.
Overview of Biofil Chemicals and Pharmaceuticals Limited (ISIN: INE829A01014) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹71.54 crores and an average daily volume of 34,078 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹0.